Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/VIFOR-PHARMA-35018535/news/Vifor-Pharma-and-Angion-Sign-License-Agreement-for-ANG-3777-in-Nephrology-Indications-31722239/?utm_source=whatsapp&utm_medium=social&utm_campaign=share